|
Hospital medicine
Nationwide survey of internal medicine hospitalists in Korea: motivation and sustainability of a hospitalist career
Seung Jun Han, Dong-Ho Shin, Nak-Hyun Kim, Eun Sun Kim, Junhwan Kim, Hye Won Kim, Sung do Moon, Sang Wook Park, Jung Hun Ohn, Chang-Yun Woo, Ki Byung Lee, Jae Hyun Lee, Han Sung Lee, Yejee Lim, Seungha Hwang
Korean J Intern Med. 2023;38(3):434-443. Published online April 11, 2023
Background/Aims: Although a management fee for hospitalist service was established in Korea, the number of hospitalists required for the system to run remains outmatched.
Methods: In January 2020 and February 2022, before and after the establishment of the hospitalist fee system respectively, cross..
|
|
|
Gastroenterology
Current trends in the management of pancreatic cystic neoplasms in Korea: a national survey
Hyung Ku Chon, Sung Hoon Moon, Sang Wook Park, Woo Hyun Paik, Chang Nyol Paik, Byoung Kwan Son, Tae Jun Song, Dong Won Ahn, Eaum Seok Lee, Yun Nah Lee, Yoon Suk Lee, Jae Min Lee, Tae Joo Jeon, Chang-Hwan Park, Kwang Bum Cho, Dong Wook Lee
Korean J Intern Med. 2022;37(1):63-72. Published online July 29, 2021
Background/Aims: The study aimed to investigate the current practice patterns in the management of pancreatic cystic neoplasms in Korea.
Methods: An electronic survey was systematically distributed by email to members of the Korean Pancreatobiliary Association from December 2019 to February 2020.
..
|
|
|
Cardiology
A pharmacodynamic study of the optimal P2Y12 inhibitor regimen for East Asian patients with acute coronary syndrome
Ji Hyun Lee, Sung Gyun Ahn, Bonil Park, Sang Wook Park, Yong Seok Kang, Jun-Won Lee, Young Jin Youn, Min-Soo Ahn, Jang-Young Kim, Byung-Su Yoo, Seung-Hwan Lee, Junghan Yoon
Korean J Intern Med. 2015;30(5):620-628. Published online August 27, 2015
Background/Aims: Newer P2Y12 inhibitors, such as prasugrel and ticagrelor, have greater antiplatelet efficacy but may increase the risk of bleeding. In this study, we compared the pharmacodynamic efficacy of prasugrel and ticagrelor in East Asian patients with acute coronary syndrome (ACS..
|
|
|
